ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sigyn Therapeutics Inc (QB)

Sigyn Therapeutics Inc (QB) (SIGY)

3.20
0.00
(0.00%)
Closed 02 February 8:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.20
Bid
3.15
Offer
4.50
Volume
-
0.00 Day's Range 0.00
3.15 52 Week Range 6.34
Market Cap
Previous Close
3.20
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
258
Shares Outstanding
17,073,325
Dividend Yield
-
PE Ratio
-13.18
Earnings Per Share (EPS)
-0.24
Revenue
-
Net Profit
-4.15M

About Sigyn Therapeutics Inc (QB)

Sigyn Therapeutics is a development-stage company focused on creating therapeutic solutions to address unmet needs in global health. Sigyn Therapy, the Companys lead product candidate, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that... Sigyn Therapeutics is a development-stage company focused on creating therapeutic solutions to address unmet needs in global health. Sigyn Therapy, the Companys lead product candidate, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. Candidate treatment indications for Sigyn Therapy include chronic inflammation and endotoxemia in end-stage renal disease patients, sepsis (leading cause of hospital deaths), community acquired pneumonia (a leading cause of death among infectious diseases), and emerging pandemic threats. The Company's development pipeline includes a cancer treatment system comprised of ChemoPrep to enhance the delivery of FDA approved chemotherapeutic agents and ChemoPure to reduce chemotherapy toxicity. Show more

Sector
Surgical,med Instr,apparatus
Industry
Jewelry Stores
Headquarters
Wilmington, Delaware, USA
Founded
2020
Sigyn Therapeutics Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker SIGY. The last closing price for Sigyn Therapeutics (QB) was US$3.20. Over the last year, Sigyn Therapeutics (QB) shares have traded in a share price range of US$ 3.15 to US$ 6.34.

Sigyn Therapeutics (QB) currently has 17,073,325 shares in issue. The market capitalisation of Sigyn Therapeutics (QB) is US$54.63 million. Sigyn Therapeutics (QB) has a price to earnings ratio (PE ratio) of -13.18.

SIGY Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4003.23.23.21403.2CS
12-2.296-41.77583697235.4965.4963.152583.84069767CS
26-1.6-33.33333333334.85.753.1513284.74723599CS
52-1.8-3656.343.157264.88904737CS
1562.775652.9411764710.4256.340.05295130.28635101CS
2601.349972.96362358791.85016.340.05259010.56450038CS

SIGY - Frequently Asked Questions (FAQ)

What is the current Sigyn Therapeutics (QB) share price?
The current share price of Sigyn Therapeutics (QB) is US$ 3.20
How many Sigyn Therapeutics (QB) shares are in issue?
Sigyn Therapeutics (QB) has 17,073,325 shares in issue
What is the market cap of Sigyn Therapeutics (QB)?
The market capitalisation of Sigyn Therapeutics (QB) is USD 54.63M
What is the 1 year trading range for Sigyn Therapeutics (QB) share price?
Sigyn Therapeutics (QB) has traded in the range of US$ 3.15 to US$ 6.34 during the past year
What is the PE ratio of Sigyn Therapeutics (QB)?
The price to earnings ratio of Sigyn Therapeutics (QB) is -13.18
What is the reporting currency for Sigyn Therapeutics (QB)?
Sigyn Therapeutics (QB) reports financial results in USD
What is the latest annual profit for Sigyn Therapeutics (QB)?
The latest annual profit of Sigyn Therapeutics (QB) is USD -4.15M
What is the registered address of Sigyn Therapeutics (QB)?
The registered address for Sigyn Therapeutics (QB) is 1013 CENTRE ROAD SUITE 403-B, WILMINGTON, DELAWARE, 19805
Which industry sector does Sigyn Therapeutics (QB) operate in?
Sigyn Therapeutics (QB) operates in the JEWELRY STORES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NXGBNxGen Brands Inc (CE)
US$ 0.003
(299,900.00%)
180.55k
DOCKFBeyond Med Technologies Inc (PK)
US$ 0.055
(54,900.00%)
3.05k
SDCCQSmileDirectClub Inc (CE)
US$ 0.0004
(39,900.00%)
52.05k
LTFDLittlefield Corporation (CE)
US$ 0.1525
(38,025.00%)
240
SGMDSugarmade Inc (CE)
US$ 0.0003
(29,900.00%)
5.94k
RTNBroot9B Holdings Inc (CE)
US$ 0.000001
(-99.97%)
666
THMOThermoGenesis Holdings Inc (CE)
US$ 0.000001
(-99.86%)
250
DOMWFPrime Drink Group Corporation (PK)
US$ 0.0012
(-99.08%)
311.03k
TTCMTautachrome Inc (CE)
US$ 0.000001
(-99.00%)
125.07k
MITJFMint Corporation (CE)
US$ 0.0001
(-99.00%)
12k
HCMCHealthier Choices Management Corporation (PK)
US$ 0.000001
(0.00%)
316.07M
HMBLHUMBL Inc (PK)
US$ 0.0007
(0.00%)
218.85M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0.00015
(-25.00%)
210.68M
RONNRonn Motor Group Inc (PK)
US$ 0.0003
(0.00%)
171.31M
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.00275
(-1.79%)
134.31M

Discussion

View Full Feed
No Posts Found

Your Recent History

Delayed Upgrade Clock